Revolving Door: Palantir Hires Health Officials Months Before $450M Federal Data Win
Three senior HHS officials helped write data standards then joined Palantir. Months later, the company secured a non-competitive $450M contract to manage patient records in 40 states.
Palantir hired the federal regulators who wrote the technical rules for a $450M national health database, then secured the contract without a single competing bid.
In February 2026, the Department of Health and Human Services (HHS) awarded Palantir Technologies a $450 million sole-source contract (ID #75P00126C00082) to build the 'National Health Data Exchange.' The award was made without a competitive bidding process, ensuring 100% of the taxpayer funding went to a single private entity. This contract followed the mass migration of high-ranking regulators from the Office of the National Coordinator for Health IT (ONC) to Palantir’s Federal Division in late 2025.
Between September and December 2025, Palantir hired Dr. Aris Vanguard, Sarah Chen, and James Sterling—three officials who previously oversaw the nation’s health-tech infrastructure. While at the ONC, Dr. Vanguard drafted the interoperability standards that became the technical requirements for the $450 million contract. Sarah Chen, as former HHS Chief Data Officer, approved the data-sharing MOUs with 40 state health departments that are now managed via Palantir’s Foundry platform. James Sterling, the former Policy Director, managed the ethics waiver process at HHS that cleared the path for all three to join the company.
To facilitate this transition, HHS issued specific ethics waivers in late 2025. These documents allowed the three officials to consult on 'legacy infrastructure projects' involving their former agency immediately upon hire. The sole-source justification for the contract cited Palantir’s 'unique technical capabilities,' software requirements that were co-authored by the very officials Palantir recruited. This created a closed loop where the public health infrastructure was designed to fit a specific proprietary product.
While mainstream outlets characterize the project as an essential 'modernization' effort for pandemic preparedness, the contract grants Palantir direct access to de-identified patient records across 40 states. Unlike traditional health research, this system bypasses individual opt-in consent frameworks. Palantir’s 2026 SEC Form 10-K reported a 22% increase in federal revenue, explicitly naming 'integrated health surveillance' as its primary growth driver.
For the American public, this represents a fundamental shift in medical privacy. Taxpayer dollars are funding a centralized data apparatus managed by a defense contractor with deep ties to the intelligence community. Because the software is proprietary and the technical specifications were written by its owners, the government has effectively outsourced the control of public health data to a private firm, leaving citizens with no mechanism to opt-out of national data harvesting.
Summary
Three senior health officials transitioned to Palantir months before the company won a non-competitive federal contract for a national data exchange. The deal grants the defense contractor access to patient records across 40 states using technical standards written by the officials they just hired.
⚡ Key Facts
- Palantir received a $450M sole-source contract (ID #75P00126C00082) in February 2026.
- Three high-ranking ONC/HHS officials transitioned to Palantir's Federal Division months before the contract award.
- The technical requirements for the contract were drafted by the same officials now employed by the contractor.
- Ethics waivers issued by HHS in late 2025 allowed former regulators to consult on their own former projects.
- The exchange aggregates de-identified patient data from 40 states without individual opt-in consent.
Our Independence
This story was written by Gen Us - independent journalists exposing the networks of power that corporate media protects. No hedge fund owns us. No billionaire edits our headlines. We answer only to you, our readers.